Hayat Pharmaceutical Industries Co. PLC (HPIC.AM)

Also known as:  HPI, Hayat
Data delayed by 15 minutes
2.42 JOD 0.000.00%
As of 30 NOV 2020 10:25 GMT|Amman SE

HPI Stock Price & Performance Powered By Knowledge Direct

Recommendation
-
Div Yield
4.132%
P/E (Last 12 Month)
6.17
Upside
-
Target Price (Mean)
-
52Wk
1.85 21 MAY
2.44 23 NOV

Open
Data not available
Previous Close
2.02 JOD
Turnover
Data not available
EPS
0.392 JOD
Volume
0
Transactions
0
Market Cap
19.19M JOD
IPO Date
05-Jun-2002
Analyst Recommendation
Sell
Hold
Buy
Analyst Rating
Strong Buy
Buy
Hold
Sell
Strong Sell

About Hayat Pharmaceutical Industries Co. PLCLast updated on: 29 June 2020

Business Summary
Production of generic drugs including capsules, tablets, dry suspension, suppositories, syrups and solutions, creams and ointments and veterinary drugs. Through its main subsidiary; distribution of generic drugs.
Country of Incorporation
Ownership Type
Established In
1994
Primary Sector
Number of Employees
237
Stock Listing
IDStock TypeCurrencyExchangeSymbol
HPIC.ASEOrdinaryJODAmman SEHPIC

Contact details

Primary address
Building: Hayat Pharmaceutical Industries Co. PLC Building
Street: Al Neel Street 11
Area: Abu Alanda Town, Al Rajeeb Area
P.O. Box: 1564
Country: Jordan
City: Amman
City Suffix: 11118
CONTACT
Region
Capital Governorate
All Health Care News

Arabtec Holding to file application for insolvent liquidation

The Board has concluded that it is no longer tenable for the Company to continue operating outside of a formal insolvency process and that it is in the best interests of the Company’s stakeholders that the Company be placed into an insolvent liquidation (subject to court approval) at the earliest opportunity

WAM (Emirates News Agency) - 30 Nov 2020
All Markets News

Ownership

Revenue
Net Income
Profit Margin
Total Assets
Total Liabilities
Debt to Assets
Operating
Investing
Financing

Executives

Dr Maher Mohammed Ali Al Kurdi
General Manager
Mr Zakaria Hussein Mustafa Abu Attiya
Deputy General Manager, Strategic Development Affairs
Mrs Najat Mohammed Sharif Husni Al Maghribi
Deputy General Manager, Technical Affairs and Quality

Board Members

Mr Salim William Salim Karadsheh
Chairman
Dr Maher Mohammed Ali Al Kurdi
Vice Chairman
Mr Walid Fuad Boulos Shehada
Director
More

Company information provided by Refinitiv

Refinitiv research team update company information from primary sources (company annual reports, press releases, company websites, corporate briefings, official statements/interviews) and reliable secondary sources (stock markets, reliable third party publications).

Peers

StocksLast Price% Change
AL-BILAD MED SRV0.590 JOD0.00
DAR ALDAWA DV/IV1.240 JOD0.81
JORDAN PHARMA 0.240 JOD0.00
Arab International Food Factories and Investment Co.--
INT CO MED INV 1.240 JOD0.00
More

Thursday Outlook: Gold rise to an over one-week high; oil prices drop

Thursday Outlook: Gold rise to an over one-week high; oil prices drop

Hopes that the pandemic will finally be brought to its knees sparked a risk-on rally in the markets

More

Most Viewed Stocks

Stock Screener

More